The estimated Net Worth of Alfonso G Zulueta is at least $18.5 Million dollars as of 1 February 2021. Mr. Zulueta owns over 16,754 units of CTS stock worth over $1,622,382 and over the last 11 years he sold CTS stock worth over $16,685,198. In addition, he makes $182,364 as Independent Director at CTS.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Zulueta CTS stock SEC Form 4 insiders trading
Alfonso has made over 27 trades of the CTS stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 16,754 units of CTS stock worth $767,836 on 1 February 2021.
The largest trade he's ever made was exercising 21,302 units of CTS stock on 7 November 2014 worth over $1,185,456. On average, Alfonso trades about 5,526 units every 48 days since 2014. As of 1 February 2021 he still owns at least 35,400 units of CTS stock.
You can see the complete history of Mr. Zulueta stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Alfonso Zulueta biography
Alfonso G. Zulueta serves as Independent Director of the Company. Mr. Zulueta is Senior Vice President of Eli Lilly and Company since 2014. He is President of Lilly International (2017 - Present). He is Member of the Executive Committee and Officer of Eli Lilly and Company (2017 - Present). He was the President of Emerging Markets and various roles of Eli Lilly and Company (1988 - 2014). Mr. Zulueta holds a bachelor's degree in economics from De La Salle University in the Philippines and an MBA from the University of Virginia. He currently serves as a director on the board of the European Federation of Pharmaceutical Industries and Associations.
What is the salary of Alfonso Zulueta?
As the Independent Director of CTS, the total compensation of Alfonso Zulueta at CTS is $182,364. There are 7 executives at CTS getting paid more, with Kieran O'Sullivan having the highest compensation of $2,438,240.
How old is Alfonso Zulueta?
Alfonso Zulueta is 57, he's been the Independent Director of CTS since 2018. There are 4 older and 4 younger executives at CTS. The oldest executive at CTS Corp. is Robert Profusek, 70, who is the Lead Independent Director.
What's Alfonso Zulueta's mailing address?
Alfonso's mailing address filed with the SEC is 4925 INDIANA AVENUE, , LISLE, IL, 60532.
Insiders trading at CTS
Over the last 21 years, insiders at CTS have traded over $11,582,788 worth of CTS stock and bought 97,128 units worth $484,822 . The most active insiders traders include William S Johnson, Gordon Hunter, and Patricia K Collawn. On average, CTS executives and independent directors trade stock every 76 days with the average trade being worth of $276,172. The most recent stock trade was executed by Martin Baumeister on 24 May 2024, trading 5,733 units of CTS stock currently worth $300,352.
What does CTS do?
cts (nyse: cts) is a designer and manufacturer of sensors, actuators and electronic components for original equipment manufacturers (oems) in the aerospace, communications, defense, industrial, information technology, medical and transportation markets. cts aims to be a leading provider of sensing and motion devices as well as connectivity components, enabling an intelligent and seamless world. this is accomplished by maintaining a strategy of investing in innovative products that fulfil the cts value proposition - sense, connect and move. cts manufactures products in north america, europe and asia.
What does CTS's logo look like?
Complete history of Mr. Zulueta stock trades at Amarin Corp, CTS, Lilly(Eli) & Co, and Syneos Health Inc
CTS executives and stock owners
CTS executives and other stock owners filed with the SEC include:
-
Kieran O'Sullivan,
Chairman of the Board, President, Chief Executive Officer -
Ashish Agrawal,
Chief Financial Officer, Vice President -
Kieran M. O'Sullivan,
Chairman, Pres & CEO -
Ashish Agrawal,
VP & CFO -
William Johnson,
Independent Director -
Robert Profusek,
Lead Independent Director -
Gordon Hunter,
Independent Director -
Alfonso Zulueta,
Independent Director -
Scott L. D'Angelo,
VP, Gen. Counsel & Sec. -
Thomas Michael White,
Corp. Controller & Principal Accounting Officer -
Scott D'Angelo,
VP, Gen. Counsel & Sec. -
Mitchell J. Walorski,
Director of Investor Relations -
Donna Costello,
Director -
Diana M Murphy,
Director -
Patricia K Collawn,
Director -
Lawrence J Clancia,
Director -
Luis Francisco Machado,
VP, General Counsel & Sec. -
Walter S Catlow,
Director -
James L Cummins,
Senior V.P. Administration -
H Tyler Buchanan,
Senior Vice President -
Amy M. Dodrill,
-
Gerald H Jr Frieling,
Director -
Donald K Schwanz,
Chief Executive Officer -
Rai Rohit,
Vice President -
George T Newhart,
V.P. Investor Relations -
Michael A Henning,
Director -
Anthony W. Urban,
Vice President -
Thomas G Cody,
Director -
Thomas A Kroll,
V.P. & Controller -
Robert Joseph Patton,
V.P., Secretary & Gen Counsel -
John Richard Dudek,
V.P. Gen. Counsel & Secretary -
Vinod M Khilnani,
S.V.P. & Chief Fin. Officer -
Dennis Paul Thornton,
Vice President -
Lawrence Joseph Iii Lyng,
Vice President -
Scott A Bowmar,
Vice President -
Richard G Cutter,
V. P. Gen. Counsel & Secretary -
Rajeeb K Nath,
Vice President -
Roger R Hemminghaus,
Director -
Donna L. Belusar,
Sr. Vice Pres. & CFO -
Donald R Schroeder,
EVP & Chief Technology Officer -
Bret Robertson,
Vice President -
Mohan S. Mahadevan,
Vice President -
Matthew W Long,
Treasurer -
Ye Jane Li,
Director -
Pratik Trivedi,
Senior Vice President -
Randy Lee Stone,
Director -
Martin Baumeister,
Senior Vice President -
Michael Edward Murray,
Senior Vice President -
Scott D'angelo,
VP & Secretary -
Thomas Michael White,
Corporate Controller & PAO